New Diet, Cognitive Training and Alzheimer’s Studies Enrolling Volunteers


Interested in volunteering for Alzheimer’s and related dementias research?

Search for clinical trials and studies near you with NIA’s clinical trials tool.

Here are some of the newest listings. Click on the trial name for details, including contact information.

Diet: MIND Diet to Prevent Cognitive Decline (Chicago, IL, and Boston, MA)

Drugs: Nilotinib for Mild to Moderate Alzheimer's Disease (Washington, DC)

Cognitive Training: Cognitive Training to Prevent Postoperative Delirium (Ann Arbor, MI)

Early-Stage Alzheimer's: Health Care Use and Costs in Mild Cognitive Impairment and Early-Stage Alzheimer's (multiple locations)

Registries

  • Alzheimer’s Prevention Registry (nationwide)—get information and updates about participating in future Alzheimer’s prevention trials.

  • GeneMatch (nationwide)—enroll to get matched to Alzheimer’s genetics studies.

  • Brain Health Registry (nationwide)—sign up for an online study of brain health and learn about possible research-study opportunities.

Get more information about these and other Alzheimer’s clinical trials. Or, call the ADEAR Center at 1-800-438-4380 (toll-free) or email adear@nia.nih.gov.

Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Google+ Basic Square
  • LinkedIn Social Icon

VIRTUAL OFFICE

 

Housebound?
No transportation?
Live in a remote area?


Get help with planning for your future no matter where you live in Georgia. All you need is a smart phone, computer or digital device with a camera for a video meeting with us directly from our office. 

Call 706.850.6910 to schedule a consultation.

Ph:  706-850-6910  |  Fax:  706-850-7115

Email: info@kimbroughlaw.net

1077 Baxter Street, Suite 700

Athens, GA 30606

500 Jesse Jewell Parkway, Suite 200

Gainesville, GA 30501

Map »

  • Facebook Basic Square
  • LinkedIn Social Icon
  • google icon

© 2020 Kimbrough Law.

All rights reserved. 

Website designed by Creative Instinct

Content plan & writing by Praesentia, Inc.